This inventor holds 2 USPTO granted patents. Top assignee: Bayer Aktiengesellschaft. Active years: 2001-2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001-2003
Title: Gerhard Mueller: Innovator in Integrin Antagonists
Introduction
Gerhard Mueller is a notable inventor based in Leverkusen, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of integrin antagonists. With a total of 2 patents, his work has the potential to impact various therapeutic areas.
Latest Patents
Mueller's latest patents focus on &bgr;-phenylalanine derivatives as integrin antagonists. These compounds are designed to interact with integrins, which are crucial for cell adhesion and signaling. The innovative approach taken in these patents could lead to advancements in treating diseases where integrin modulation is beneficial.
Career Highlights
Throughout his career, Gerhard Mueller has been associated with Bayer Aktiengesellschaft, a leading global pharmaceutical company. His work at Bayer has allowed him to collaborate with some of the brightest minds in the industry, contributing to groundbreaking research and development.
Collaborations
Some of his notable coworkers include Andreas Schoop and Joerg Keldenich. Their collaborative efforts have further enhanced the research environment, fostering innovation and creativity in the development of new therapeutic solutions.
Conclusion
Gerhard Mueller's contributions to the field of integrin antagonists exemplify the importance of innovation in pharmaceuticals. His patents and collaborations reflect a commitment to advancing medical science and improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile